1-3 of 3
Maria Miscio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Very Poor Outcome of Patients with Relapsed/Refractory Aggressive B Cell Lymphoma after Autologous Stem Cell Transplantation (ASCT) or High Dose of Methotrexate and Cytarabine (HD-MTX/ARA-C) Regimens in the Clinical Care Setting

Nicola Bianchetti, Alessandra Tucci, Alessandro Re, MD, Chiara Pagani, MD, Chiara Cattaneo, MD, Maria Miscio, Fabio Facchetti, Simona Fisogni, MD, Piera Balzarini, Domenico Albano, Giovanni Bosio, Francesco Bertagna, Giuseppe Rossi
Journal: Blood
Blood (2018) 132 (Supplement 1): 4232.
https://doi.org/10.1182/blood-2018-99-119090
Published: 2018
Journal Articles

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Alessandra Tucci, MD, Anna Guidetti, MD, Anna Dodero, MD, Francesca Schieppati, MD, Alessandro Re, MD, Nicola Bianchetti, MD, Chiara Bottelli, MD, Angela Passi, MD, Maria Miscio, Simona Fisogni, MD, Piera Balzarini, Fabio Facchetti, MD, Paolo Corradini, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4154.
https://doi.org/10.1182/blood.V130.Suppl_1.4154.4154
Published: 2017
Journal Articles

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Annalisa Peli, MD, Nicola Bianchetti, MD, Angela Passi, MD, Emanuele Focà, MD, Maria Miscio, Francesco Castelli, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5223.
https://doi.org/10.1182/blood.V130.Suppl_1.5223.5223
Published: 2017